Processa Pharmaceuticals Inc (OQ:PCSA)

Business Focus: Pharmaceuticals

Latest 10 SEC filings (by transaction date) for PCSA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 28th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 8/24 Feb 7/24 Young David Direct Ownership Common Stock P - Open market or private purchase 21,000 $2.45
Feb 7/24 Feb 6/24 Young David Direct Ownership Common Stock P - Open market or private purchase 20,000 $2.53
Feb 1/24 Feb 1/24 Lin Patrick Direct Ownership Common Stock P - Open market or private purchase 1,500 $2.40
Feb 1/24 Jan 31/24 Lin Patrick Direct Ownership Common Stock P - Open market or private purchase 2,500 $2.37
Jan 31/24 Jan 30/24 Ng George K Indirect Ownership Common Stock P - Open market or private purchase 10,000 $2.70
Jan 31/24 Jan 30/24 Yorke Justin W Indirect Ownership Common Stock P - Open market or private purchase 8,000 $2.69
Nov 28/23 Nov 21/23 Yorke Justin W Indirect Ownership Common Stock J - Other transaction -55,267  
Oct 23/23 Oct 12/23 Yorke Justin W Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 6,000 $0.300
Oct 12/23 Oct 12/23 Guy Wendy Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 14,771 $0.340
Oct 12/23 Oct 12/23 Ng George K Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 100,000 $0.250
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for PCSA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 28th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 8/24 Feb 7/24 Young David Direct Ownership Common Stock P - Open market or private purchase 21,000 $2.45
Feb 7/24 Feb 6/24 Young David Direct Ownership Common Stock P - Open market or private purchase 20,000 $2.53
Feb 1/24 Feb 1/24 Lin Patrick Direct Ownership Common Stock P - Open market or private purchase 1,500 $2.40
Feb 1/24 Jan 31/24 Lin Patrick Direct Ownership Common Stock P - Open market or private purchase 2,500 $2.37
Jan 31/24 Jan 30/24 Ng George K Indirect Ownership Common Stock P - Open market or private purchase 10,000 $2.70
Jan 31/24 Jan 30/24 Yorke Justin W Indirect Ownership Common Stock P - Open market or private purchase 8,000 $2.69
Nov 28/23 Nov 21/23 Yorke Justin W Indirect Ownership Common Stock J - Other transaction -55,267  
Oct 23/23 Oct 12/23 Yorke Justin W Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 6,000 $0.300
Oct 12/23 Oct 12/23 Guy Wendy Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 14,771 $0.340
Oct 12/23 Oct 12/23 Ng George K Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 100,000 $0.250
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $PCSA

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Eyepoint Pharmaceuticals (OQ:EYPT)
AbbVie (N:ABBV)
Merck & Co (N:MRK)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.